Comparative performance of CTG-3D and resazurin assays in low-density gelatin-alginate bioprinted mesenchymal stromal cell constructs
摘要
3D bioprinting of adipose mesenchymal stromal cells (ASC), as single cells or spheroids, underpins the development of experimental biodressing and secretome-oriented workflows. The assessment of viability-associated readouts is technically challenging in hydrogels. We aimed to evaluate the applicability and comparative performance of CellTiter Glo 3D (CTG-3D) and resazurin in a defined ASC-laden gelatin-alginate architecture intended for downstream workflows in 3D bioprinted constructs.
MethodsMSCs from C57BL/6 adipose tissue (P3) were characterized and incorporated as free cells into a gelatin–alginate bioink, bioprinted and cultured in DMEM-F12 with or without 10% FBS. After 48 h, punched fragments were analyzed with CTG-3D and Resazurin following manufacturer instructions. Luminescence and absorbance were read on an EnVision system.
ResultsBoth assays detected the expected increase in viability-associated readouts in FBS-rich medium. CTG-3D showed statistical sensitivity (p = 0.0039) comparable with Resazurin (p = 0.0013). The similarity between assays likely reflects the low-density hydrogel, permitting adequate reagent diffusion and viability-related signal generation.
ConclusionThe gelatin–alginate bioprinted model supports short-term MSC viability-associated readouts and is suitable for refining culture parameters and bioactive factor release toward experimental biodressing-oriented workflows. CTG-3D and Resazurin perform comparably in this architecture, but assay choice should balance cost and sensitivity according to construct density and complexity.
Graphical Abstract